4-phenylbutyrate and valproate treatment attenuates the progression of atherosclerosis and stabilizes existing plaques

The pharmacological attenuation of ER stress or inhibition of GSK3α/β impedes the development of atherosclerosis in Ldlr−/− mice and appears to promote the stabilization of existing lesions.